William C. Cromwell

Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial

Frederick J. Raal, Raúl D. Santos, Dirk Blom et al. · The Lancet · 2010 · 897 citations

Homozygous Familial Hypercholesterolaemia, Oxysterol, Cardiovascular Disease +7

Familial Hypercholesterolemia: Screening, diagnosis and management of pediatric and adult patients

Anne C. Goldberg, Paul N. Hopkins, Peter P. Tóth et al. · Journal of clinical lipidology · 2011 · 613 citations

Metabolic Syndrome, Familial Hypercholesterolemia, Lipid Disorder +8

Familial Hypercholesterolemia: Screening, diagnosis and management of pediatric and adult patients

Anne C. Goldberg, Paul N. Hopkins, Peter P. Tóth et al. · Journal of clinical lipidology · 2011 · 538 citations

Metabolic Syndrome, Familial Hypercholesterolemia, Lipid Disorder +8

LDL particle number and risk of future cardiovascular disease in the Framingham Offspring Study—Implications for LDL management

William C. Cromwell, James D. Otvos, Michelle J. Keyes et al. · Journal of clinical lipidology · 2007 · 433 citations · Full text

Metabolic Syndrome, Lipid Disorder, Cardiovascular Epidemiology +10

Cyclodextrin-adamantanecarboxylate inclusion complexes: studies of the variation in cavity size

William C. Cromwell, Katarina Byström, Maurice R. Eftink · The Journal of Physical Chemistry · 1985 · 274 citations

Molecular Sciences, Engineering, Physicochemical Analysis +12